Management of allergic conjunctivitis: an evaluation of the perceived comfort and therapeutic efficacy of olopatadine 0.2% and azelastine 0.05% from two prospective studies.

Patients using olopatadine 0.2% also reported significantly better comfort scores than patients using azelastine 0.05% at both 30 seconds (p = 0.0479) and 1 minute (p = 0.0240); although olopatadine 0.2% was numerically better at 2 minutes, this did not reach statistical significance (p = 0.2984).

also in 111,027 other papers